ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,219.71
0.11%
US Tech 100
17,698.40
0.33%
다우존스 지수
39,503.33
0.29%
Bitcoin
62,251.62
-1.26%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Adicet Bio Inc (ACET)

  7. Adicet Bio Inc (ACET) 뉴스

ACET

Adicet Bio (ACET)

Adicet Bio Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:ACET
일자시간출처헤드라인심볼기업
2024/05/1019:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACETAdicet Bio Inc
2024/05/0720:00Business WireAdicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences ConferenceNASDAQ:ACETAdicet Bio Inc
2024/05/0106:10Business WireAdicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACETAdicet Bio Inc
2024/04/2305:30Business WireAdicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual MeetingNASDAQ:ACETAdicet Bio Inc
2024/04/0820:00Business WireAdicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual ConferenceNASDAQ:ACETAdicet Bio Inc
2024/03/2906:19Business WireAdicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACETAdicet Bio Inc
2024/03/2005:10Business WireAdicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company ProgressNASDAQ:ACETAdicet Bio Inc
2024/03/1120:00Business WireAdicet Bio to Participate in a Fireside Chat at the H.C. Wainwright 2nd Annual Cell Therapy Virtual ConferenceNASDAQ:ACETAdicet Bio Inc
2024/03/0109:46Business WireAdicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACETAdicet Bio Inc
2024/02/0606:01Business WireAdicet Bio to Participate in a Fireside Chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceNASDAQ:ACETAdicet Bio Inc
2024/02/0301:49Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ACETAdicet Bio Inc
2024/02/0106:39Business WireAdicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACETAdicet Bio Inc
2024/01/2709:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
2024/01/2709:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
2024/01/2606:01Business WireAdicet Bio, Inc. Announces Closing of $98 Million Public Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional SharesNASDAQ:ACETAdicet Bio Inc
2024/01/2506:34Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACETAdicet Bio Inc
2024/01/2506:32Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ACETAdicet Bio Inc
2024/01/2313:43Business WireAdicet Bio, Inc. Announces Pricing of Public OfferingNASDAQ:ACETAdicet Bio Inc
2024/01/2306:30Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ACETAdicet Bio Inc
2024/01/2306:28Business WireAdicet Bio, Inc. Announces Proposed Public OfferingNASDAQ:ACETAdicet Bio Inc
2024/01/2006:05Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ACETAdicet Bio Inc
2024/01/1621:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACETAdicet Bio Inc
2024/01/0421:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACETAdicet Bio Inc
2024/01/0421:00Business WireAdicet Provides Corporate Update and Highlights Strategic Priorities for 2024NASDAQ:ACETAdicet Bio Inc
2024/01/0406:01Business WireAdicet Bio to Host Conference Call to Provide Updates on its Clinical Pipeline and Corporate OutlookNASDAQ:ACETAdicet Bio Inc
2023/12/3006:50Business WireAdicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACETAdicet Bio Inc
2023/12/1102:00Business WireAdicet Bio Highlights ADI-001 Expansion, Persistence and Pharmacodynamic Profile from Ongoing Phase 1 Study at the 65th American Society of Hematology (ASH) Annual MeetingNASDAQ:ACETAdicet Bio Inc
2023/11/1406:42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACETAdicet Bio Inc
2023/11/0906:14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ACETAdicet Bio Inc
2023/11/0906:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACETAdicet Bio Inc
 검색 관련기사 보기:NASDAQ:ACET

최근 히스토리

FX
USDGBP
US Dollar vs Sterling
CCOM
US30
US 30
CCOM
US500
US 500
NASDAQ
GOOGL
Alphabet
CCOM
US100
US Tech 100
AMEX
SPY
SPDR S&P 500
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
NVDA
NVIDIA
NYSE
MRK
Merck
NYSE
DIS
Walt Disney
COIN
SOLUSD
Solana
NYSE
XOM
Exxon Mobil
PM
XAUUSD
Gold vs US Dollar
FX
USDJPY
US Dollar vs Yen
NASDAQ
AMZN
Amazon.com
NYSE
CVX
Chevron
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유